DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
18.01
+0.97 (5.69%)
Apr 22, 2025, 2:45 PM CST
SHA:603233 Market Cap
SHA:603233 has a market cap or net worth of 19.41 billion as of April 21, 2025. Its market cap has decreased by -21.73% in one year.
Market Cap
19.41B
Enterprise Value
22.26B
Revenue
26.54B
Ranking
n/a
PE Ratio
22.76
Stock Price
18.01
Market Cap Chart
Since July 31, 2017, SHA:603233's market cap has increased from 14.24B to 19.41B, an increase of 36.27%. That is a compound annual growth rate of 4.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 305.21B |
Shenzhen Mindray Bio-Medical Electronics | 262.53B |
WuXi AppTec | 151.08B |
Zhangzhou Pientzehuang Pharmaceutical., | 125.12B |
Aier Eye Hospital Group | 119.65B |
Shanghai United Imaging Healthcare | 106.40B |
Sichuan Biokin Pharmaceutical | 103.86B |
Yunnan Baiyao Group Co.,Ltd | 102.51B |